The recognized involvement of the PD-1/PDL1 axis in cancer and during infections has provided the incentive to investigate the role of these immune response controllers in COVID-19, however, leading to conflicting and inconclusive results [30,31,32,33,34]. The gene discussed is CD274; the disease is cancer.